-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EKW06Kiwws0nauHmCANX2PLbIWImPA8n0/qu+q9X6NT903SeRreolS/e41J/nlYC LZvH2iqdU7SpRui/I7Y3+A== 0001193125-05-002451.txt : 20050106 0001193125-05-002451.hdr.sgml : 20050106 20050106164754 ACCESSION NUMBER: 0001193125-05-002451 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050106 DATE AS OF CHANGE: 20050106 EFFECTIVENESS DATE: 20050106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OCULAR SCIENCES INC /DE/ CENTRAL INDEX KEY: 0000882484 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 942985696 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-22623 FILM NUMBER: 05516154 BUSINESS ADDRESS: STREET 1: 1855 GATEWAY BLVD STREET 2: SUITE 700 CITY: CONCORD STATE: CA ZIP: 94520 BUSINESS PHONE: 1-925-969-7000 MAIL ADDRESS: STREET 1: 1855 GATEWAY BLVD STREET 2: SUITE 700 CITY: CONCORD STATE: CA ZIP: 94520 FORMER COMPANY: FORMER CONFORMED NAME: O S I CORP DATE OF NAME CHANGE: 19970506 15-12G 1 d1512g.htm CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION Certification and Notice of Termination of Registration

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION

12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE

REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 0-22623

 

 

Ocular Sciences, Inc.

(Exact name of registrant as specified in its charter)

 

 

1855 Gateway Boulevard, Suite 700, Concord, CA 94520

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, par value $0.10 per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)(i)    x    Rule 12h-3(b)(1)(i)    x
Rule 12g-4(a)(1)(ii)    ¨    Rule 12h-3(b)(1)(ii)    ¨
Rule 12g-4(a)(2)(i)    ¨    Rule 12h-3(b)(2)(i)    ¨
Rule 12g-4(a)(2)(ii)    ¨    Rule 12h-3(b)(2)(ii)    ¨
          Rule 15d-6    ¨

 

Approximate number of holders of record as of the certification or notice date: One (1)

 

Pursuant to the requirements of the Securities Exchange Act of 1934 Ocular Sciences, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

    TCC ACQUISITION CORP., successor by merger
Date: January 6, 2005   By:  

/s/ Carol R. Kaufman

        Carol R. Kaufman, Vice President and Secretary

 

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

 

SEC2069(12-04)

    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

 -----END PRIVACY-ENHANCED MESSAGE-----